PET Resources

In addition to the resources provided below, visit our curated database of published references put together by a team of experts to support the American Society of Nuclear Cardiology and Society of Nuclear Medicineand Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.

Upcoming Meetings

New! Pet Workshops
May 4-5 & November 9-10, 2019
Mclean, VA (just outside Washington, DC)

Quality

PET Case Studies

Guidelines
Archived Webinar: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and ASNC- 2018
 (Offers 1 CME credit for physicians and 1 CE credit to technologists; Expires: March 20, 2019)

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures -2016
PET myocardial perfusion and metabolism clinical imaging-2009

Practice Points (member-only resource: Log-in to access)
Positron Emission Tomography Assessment of Myocardial Viability
PET Myocardial Perfusion Imaging
Cardiac F-18 FDG PET

Position Statements
American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET-2016

Quick Reference Guides
Myocardial Perfusion Positron Emission Tomography (PET)-2016

Videos
Practical Considerations for Developing a PET Program
Cardiac PET: The Time is Right
Start Up Strategies for Cardiac PET
Cardiac PET from a Clinician's Perspective
PET Tracers for Clinical Cardiovascular Imaging

Advocacy

Archived Webinar- Coding for Myocardial Blood Flow in PET- 2018

Category III Code for Absolute Quantitation of Myocardial Blood Flow in PET- 0482T

Model Coverage Policy for PET- 2014
This document is intended as a model coverage policy for cardiac positron emission tomography (PET) imaging studies and delineates under which clinical situations such a study is indicated. This document examines a variety of patient clinical indications and symptoms which support the use of cardiac PET by cross-referencing the indication with the appropriate use criteria (AUC) for radionuclide studies developed by the American College of Cardiology (ACC)/American Society of Nuclear Cardiology (ASNC) in 2005 and subsequently revised in 2009. In addition, the use of cardiac PET in patients with the indications delineated in the policy is supported by references to an abundance of the literature in the provided scenarios. Finally, we have provided the International Classification of Diseases (ICD)-9 codes which correlate to each of the indications to demonstrate which codes, or ranges of codes, are appropriate for each clinical indication.